• Perphenazine: Expanding Frontiers in Dopamine Antagonist ...

  2026-03-23

  Explore the unique pharmacological profile of Perphenazine, a potent dopamine D2 receptor antagonist, and its emerging role in host-directed antibacterial therapies. This in-depth review unpacks its multi-receptor actions, advanced applications, and novel research frontiers beyond conventional neuropharmacology.

• Perphenazine: A Dopamine Antagonist Redefining Neuropharm...

  2026-03-23

  Explore Perphenazine, a dopamine D2 receptor antagonist, as a frontier tool in neuropharmacology research. This article uniquely investigates its multifaceted mechanisms in cell death induction, dopamine signaling pathway inhibition, and host-directed antibacterial strategies, offering advanced insights beyond traditional applications.

• Perphenazine: Expanding Neuropharmacology and Host-Direct...

  2026-03-22

  Explore Perphenazine's unique role as a dopamine D2 receptor antagonist in neuropharmacology and host-directed antibacterial research. This comprehensive analysis reveals untapped applications and mechanistic insights, setting it apart from existing literature.

• Perphenazine: Dopamine D2 Antagonist Empowering Neurophar...

  2026-03-21

  Perphenazine stands out as a robust dopamine antagonist for neuropharmacology research, offering unique advantages in dissecting dopamine signaling, inducing mitochondria-mediated cell death, and modulating host immune responses. Tailored for advanced workflows, this phenothiazine derivative from APExBIO ensures reproducibility across schizophrenia, psychosis, and host-pathogen interaction studies.

• Perphenazine: Mechanistic Insights and Emerging Roles in ...

  2026-03-20

  Explore the multifaceted applications of Perphenazine, a dopamine D2 receptor antagonist, in neuropharmacology and host-directed antibacterial research. This in-depth review uncovers advanced mechanistic insights, including mitochondrial cell death induction and macrophage-mediated immunity, offering a distinct perspective beyond standard workflow guidance.

• Perphenazine (SKU B6157): Reliable Solutions for Cell-Bas...

  2026-03-20

  This article provides scenario-driven guidance for biomedical researchers and lab technicians considering Perphenazine (SKU B6157) in cell viability, proliferation, and host-pathogen interaction assays. Drawing on quantitative data and peer-reviewed studies, it details best practices, addresses common pitfalls in neuropharmacology and immunology research, and highlights how APExBIO’s Perphenazine ensures reproducibility and workflow compatibility.

• Perphenazine (SKU B6157): Reliable Solutions for Cell Via...

  2026-03-19

  This article provides scenario-driven guidance for researchers and lab technicians considering Perphenazine (SKU B6157) in cell viability, proliferation, and host-pathogen interaction assays. Drawing on quantitative data and peer-reviewed studies, it details best practices, addresses common pitfalls in neuropharmacology and immunology research, and highlights how APExBIO’s Perphenazine ensures reproducibility and workflow compatibility.

• Crizotinib hydrochloride (SKU B3608): Precision Tools for...

  2026-03-19

  This article provides an evidence-based, scenario-driven guide for using Crizotinib hydrochloride (SKU B3608) in advanced cancer biology workflows, focusing on cell viability, proliferation, and cytotoxicity assays. Drawing on latest literature, it addresses practical challenges in patient-derived assembloid models and demonstrates how Crizotinib hydrochloride delivers reproducibility, kinase selectivity, and workflow efficiency.

• MCC950 Sodium (B7946): Selective NLRP3 Inflammasome Inhib...

  2026-03-18

  MCC950 sodium is a highly selective NLRP3 inflammasome inhibitor with nanomolar potency in macrophages. This article details its mechanism, key benchmarks, and applications in inflammatory and autoimmune disease research.

• Nelfinavir Mesylate: Precision HIV-1 Protease Inhibitor a...

  2026-03-18

  Explore how Nelfinavir Mesylate, a potent HIV-1 protease inhibitor, is redefining antiretroviral drug development and ferroptosis research. This article uniquely analyzes its integration into advanced HIV infection research and caspase signaling studies, while revealing underexplored mechanistic intersections for antiviral and cancer therapy innovation.

• SB 431542: Selective ATP-Competitive ALK5 Inhibitor for T...

  2026-03-17

  SB 431542 is a potent, selective ALK5 inhibitor that blocks TGF-β signaling in cellular and animal models. This article details its mechanism, evidence base, and workflow integration for cancer and fibrosis research, with precise, machine-readable claims.

• Captopril (SKU A4078): Data-Driven Solutions for Reliable...

  2026-03-17

  This article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how Captopril (SKU A4078) offers validated, reproducible solutions for ACE inhibition, apoptosis studies, and bradykinin pathway research. Scenario-driven Q&A blocks provide practical guidance for bench scientists, highlighting APExBIO's quality, solubility, and workflow compatibility. Explore how leveraging Captopril ensures experimental robustness from protocol design to data interpretation.

• (-)-JQ1: The Gold-Standard Inactive Control for BET Bromo...

  2026-03-16

  (-)-JQ1 is a rigorously validated inactive control compound for BET bromodomain inhibition, essential for specificity benchmarking in epigenetics and cancer biology research. By serving as the non-binding stereoisomer of (+)-JQ1, (-)-JQ1 enables precise differentiation of on-target versus off-target effects in BRD4-dependent experimental systems.

• Redox State Intelligence in Translational Oncology: Strat...

  2026-03-16

  This thought-leadership article explores the critical roles of glutathione metabolism and redox state analysis in the evolving field of tumor immunometabolism. By integrating foundational mechanistic insights, emerging research on the hypoxic tumor microenvironment, and the latest assay innovations, we offer a translational roadmap for researchers. The GSH and GSSG Assay Kit from APExBIO is positioned as a pivotal tool, enabling precision measurement and interpretation of redox dynamics with direct relevance to oncology, neurodegeneration, and beyond.

• PR-619: Broad-Spectrum Reversible DUB Inhibitor for Ubiqu...

  2026-03-15

  PR-619 is a reversible, broad-spectrum deubiquitylating enzymes inhibitor (DUB inhibitor) used to dissect ubiquitination pathways in cancer biology and neurodegenerative disease models. It accumulates ubiquitinated proteins without impairing proteasomal catalytic activity. The compound’s unique selectivity and experimental reliability distinguish it as a premier tool for ubiquitin-proteasome system research.

454 records 24/31 page Previous Next First page 上5页 2122232425 下5页 Last page